To validate the presence of unsaturated fatty acids in LDs, we treated LD-rich melanoma cells with desaturase inhibitors, CAY10566 and SC26196, for inhibiting Stearoyl-CoA desaturase-1 (SCD) and FADS2, respectively. The gene discussed is SCD; the disease is melanoma.